These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8182514)

  • 1. Interaction of drug metabolites with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon R; Thakore E; Wilson L; Duff H
    J Pharmacol Exp Ther; 1994 May; 269(2):477-81. PubMed ID: 8182514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
    Sheldon RS; Duff HJ; Thakore E; Hill RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):187-94. PubMed ID: 8301556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
    Hill RJ; Duff HJ; Sheldon RS
    Mol Pharmacol; 1989 Jul; 36(1):150-9. PubMed ID: 2546048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring and link requirements for tocainide binding to the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon RS; Thakore E
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1005-10. PubMed ID: 7891310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
    Hill RJ; Duff HJ; Sheldon RS
    Mol Pharmacol; 1988 Nov; 34(5):659-63. PubMed ID: 2848186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon RS; Hill RJ; Taouis M; Wilson LM
    Mol Pharmacol; 1991 May; 39(5):609-14. PubMed ID: 1851959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel.
    Sheldon RS; Hill RJ; Cannon NJ; Duff HJ
    Circ Res; 1989 Aug; 65(2):477-82. PubMed ID: 2546697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug.
    Taouis M; Sheldon RS; Duff HJ
    J Clin Invest; 1991 Aug; 88(2):375-8. PubMed ID: 1650791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels.
    Sheldon RS; Cannon NJ; Duff HJ
    Circ Res; 1987 Oct; 61(4):492-7. PubMed ID: 2443266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I antiarrhythmic drug effects on ouabain binding to guinea pig cardiac Na+ -K+ ATPase.
    Almotrefi AA; Basco C; Moorji A; Dzimiri N
    Can J Physiol Pharmacol; 1999 Nov; 77(11):866-70. PubMed ID: 10593659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
    Sheldon RS; Duff HJ; Hill RJ
    Clin Invest Med; 1991 Oct; 14(5):458-65. PubMed ID: 1660368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor.
    Hill RJ; Thakore E; Taouis M; Duff HJ; Sheldon RS
    Eur J Pharmacol; 1991 Oct; 203(1):51-8. PubMed ID: 1665791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myocardial levels of the antiarrhythmic drugs: clinical relevance.
    Ferrari M; Padrini R; Piovan D; Bova S; Moretto R; Cargnelli G
    G Ital Cardiol; 1986 Aug; 16(8):660-2. PubMed ID: 3792731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioligand exchange binding cannot directly determine the dissociation constant (Kd) of the rat ventral prostate nuclear androgen receptor: valid Kd determinations require additional uptake binding data.
    Chapman JC; Freeh SM; Michael SD
    Arch Biochem Biophys; 1993 Dec; 307(2):242-7. PubMed ID: 8274009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
    J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular modeling of anti-arrhythmia agents in class Ia and Ib--model conceptions of different binding receptors].
    Marrer S
    Pharm Acta Helv; 1989; 64(12):338-44. PubMed ID: 2616583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cutaneous analgesic effect of class I antiarrhythmic drugs.
    Tzeng JI; Cheng KI; Huang KL; Chen YW; Chu KS; Chu CC; Wang JJ
    Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytes.
    Fatholahi M; Xiang Y; Wu Y; Li Y; Wu L; Dhalla AK; Belardinelli L; Shryock JC
    J Pharmacol Exp Ther; 2006 May; 317(2):676-84. PubMed ID: 16410404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.